Association of parathyroid hormone and 25-OH-vitamin d levels with arterial stiffness in postmenopausal women with vitamin D insufficiency

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 10, 2012, Pages 924-931

  Pirro, Matteo ^a   Manfredelli, Maria Rosaria ^a   Helou, Rony S ^a   Scarponi, Anna Maria ^a   Schillaci, Giuseppe ^a   Bagaglia, Francesco ^a   Melis, Francesco ^a   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Aortic stiffness; Parathyroid hormone; Postmenopausal; Vitamin d

Indexed keywords

ALBUMIN; CALCIFEDIOL; CALCIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; PARATHYROID HORMONE;

AGED; ALBUMIN BLOOD LEVEL; AORTIC PULSE WAVE VELOCITY; ARTERIAL STIFFNESS; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; OSSIFICATION; POSTMENOPAUSE; PULSE WAVE; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; BONE DENSITY; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PARATHYROID HORMONE; POSTMENOPAUSE; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84869007741     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13128     Document Type: Article

References (52)

1. Vlachopoulos C, Aznaouridis K, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol, 2010; 55: 1318-1327
2. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension, 2002; 39: 10-15
3. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke, 2003; 34: 1203-1206
4. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation, 2002; 106: 2085-2090
5. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in endstage renal disease. Circulation, 1999; 99: 2434-2439
6. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A; Health ABC Study: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation, 2005; 111: 3384-3390
7. O'Rourke MF, Nichols WW: Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension, 2005; 45: 652-658
8. Pirro M, Schillaci G, Savarese G, Gemelli F, Vaudo G, Siepi D, Bagaglia F, Mannarino E: Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia. Eur J Clin Invest, 2004; 34: 335-341
9. Rosa J, Raska I Jr, Wichterle D, Petrak O, Strauch B, Somloova Z, Zelinka T, Holaj R, Widimsky J Jr: Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy. Hypertens Res, 2011, 34: 296-300
10. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, Scanlon MF, Davies JS: Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab, 2000; 85: 3515-3519
11. Schillaci G, Pucci G, Pirro M, Monacelli M, Scarponi AM, Manfredelli MR, Rondelli F, Avenia N, Mannarino E: Large-artery stiffness: A reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis, 2011; 218: 96-101
12. Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ: Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab, 2005; 90: 3326-3330
13. Kosch M, Hausberg M, Barenbrock M, Posadzy-Malaczynska A, Kisters K, Rahn KH: Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy. Clin Nephrol, 2001; 55: 303-308
14. Tordjman KM, Yaron M, Izkhakov E, Osher E, Shenkerman G, Marcus-Perlman Y, Stern N: Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol, 2010; 162: 925-933
15. Suzuki T, Yonemura K, Maruyama Y, Takahashi T, Takita T, Furuhashi M, Hishida A: Impact of serum parathyroid hormone concentration and its regulatory factors on arterial stiffness in patients undergoing maintenance hemodialysis. Blood Purif, 2004; 22: 293-297
16. Jung JY, Hwang YH, Lee SW, Lee H, Kim DK, Kim S, Oh YG, Yang J, Joo KW, Ahn C, Oh KH: Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. Nephrol Dial Transplant, 2010; 25: 4041-4048
17. Rothe HM, Liangos O, Biggar P, Petermann A, Ketteler M: Cinacalcet treatment of primary hyperparathyroidism. Int J Endocrinol, 2011; 415719
18. Mercadal Orfila G, Blasco Mascaró I: Retrospective assessment of effective and safety of cinacalcet for the treatment of secondary hyperparathyroidism depending on basal iPTH level. Farm Hosp, 2011; Apr 21
19. Bonet J, Bayés B, Fernández-Crespo P, Casals M, López-Ayerbe J, Romero R: Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism - results of a small-scale, prospective, observational study. Clin Nephrol, 2011; 75: 181-187
20. Holick MF: Vitamin D deficiency. N Engl J Med, 2007; 19; 357: 266-281
21. Mezquita-Raya P, Muñoz-Torres M, Luna JD, Luna V, Lopez-Rodriguez F, Torres-Vela E, Escobar-Jiménez F: Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res, 2001; 16: 1408-1415
22. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med, 2007; 167: 1159-1165
23. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation, 2008; 117: 503-511
24. Artaza JN, Mehrotra R, Norris KC: Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol, 2009; 4: 1515-1522
25. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol, 2007; 18: 613-620
26. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, Kavtaradze N, Uphoff I, Hooper C, Tangpricha V, Alexander RW, Brigham K, Quyyumi AA: Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol, 2011; 58: 186-192
27. Cunningham J, Locatelli F, Rodriguez M: Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol, 2011; 6: 913-921
28. Thacher TD, Clarke BL: Vitamin D insufficiency. Mayo Clin Proc, 2011; 86: 50-60
29. Maetani M, Maskarinec G, Franke AA, Cooney RV. Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr Cancer, 2009; 61: 225-231
30. Montomoli M, Gonnelli S, Giacchi M, Mattei R, Cuda C, Rossi S, Gennari C: Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women. Eur J Clin Nutr, 2002; 56: 21-30
31. Pirro M, Schillaci G, Paltriccia R, Bagaglia F, Menecali C, Mannarino MR, Capanni M, Velardi A, Mannarino E: Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol, 2006; 26: 2530-2535
32. Pirro M, Schillaci G, Mannarino MR, Savarese G, Vaudo G, Siepi D, Paltriccia R, Mannarino E: Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. Nutr Metab Cardiovasc Dis, 2007; 7: 436-441
33. Pirro M, Schillaci G, Savarese G, Gemelli F, Mannarino MR, Siepi D, Bagaglia F, Mannarino E: Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil, 2004; 11: 497-502
34. Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab, 2010; 95: 2630-2633
35. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr, 2008; 87: 1080S-1086S
36. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM: Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 2007; 25: 1105-1187
37. Adji A, O'Rourke MF, Namasivayam M: Arterial stiffness, its assessment, prognostic value, and implications for treatment. Am J Hypertens, 2011; 24: 5-17
38. Yokoyama H, Shoji T, Kimoto E, Shinohara K, Tanaka S, Koyama H, Emoto M, Nishizawa Y. Pulse wave velocity in lower-limb arteries among diabetic patients with peripheral arterial disease. J Atheroscler Thromb, 2003; 10: 253-258
39. Shinohara K, Shoji T, Kimoto E, Yokoyama H, Fujiwara S, Hatsuda S, Maeno T, Shoji T, Fukumoto S, Emoto M, Koyama H, Nishizawa Y. Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. J Atheroscler Thromb, 2005; 12: 205-210
40. Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J: Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation, 2009; 119: 2765-2771
41. Hatsuda S, Shoji T, Shinohara K, Kimoto E, Mori K, Fukumoto S, Koyama H, Emoto M, Nishizawa Y. Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus. J Atheroscler Thromb, 2006; 13: 114-121
42. Madero M, Wassel CL, Peralta CA, Najjar SS, Sutton-Tyrrell K, Fried LF, de Boer IH, Shlipak MG, Newman AB, Hausman D, Sarnak MJ, Kritchevsky SB, Ix JH: Markers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the health aging and body composition study. Am J Hypertens, 2011; 24: 755-761
43. Kanbay M, Afsar B, Gusbeth-Tatomir P, Covic A: Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol, 2010; 42: 741-752
44. Gu Y, Cheng LT, Chen HM, Sun XY, Tang LJ, Guo LJ, Axelsson J, Wang T: Strong association between nutritional markers and arterial stiffness in continuous ambulatory peritoneal dialysis patients. Blood Purif, 2008; 26: 340-346
45. Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA: Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol, 2002; 13: 177-183
46. Leboeuf A, Mac-Way F, Utescu MS, De Serres SA, Douville P, Desmeules S, Lebel M, Agharazii M: Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant, 2011; Mar 31
47. Persy V, D'Haese P: Vascular calcification and bone disease: the calcification paradox. Trends Mol Med, 2009; 15: 405-416
48. Cecelja M, Jiang B, Bevan L, Frost ML, Spector TD, Chowienczyk PJ: Arterial stiffening relates to arterial calcification but not to noncalcified atheroma in women. A twin study. J Am Coll Cardiol, 2011; 57: 1480-1486
49. Perkovic V, Hewitson TD, Kelynack KJ, Martic M, Tait MG, Becker GJ: Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res, 2003; 26: 27-33
50. Jono S, Nishizawa Y, Shioi A, Morii H: Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 1999; 17: 1135-1142
51. Fitzpatrick LA, Bilezikian JP, Silverberg SJ: Parathyroid hormone and the cardiovascular system. Curr Osteoporos Rep, 2008; 6: 77-83
52. Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, Gordon EJ, Xu J, Langefeld CD, Divers J: Vitamin D, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metab, 2010; 95: 1076-1083